Use of 3′ Rapid Amplification of cDNA Ends (3′ RACE)-Based Targeted RNA Sequencing for Profiling of Druggable Genetic Alterations in Urothelial Carcinomas
Genomic studies of urothelial carcinoma have identified inactivation of tumor suppressor genes (e.g., TP53, ARID1A) and activation of oncogenes (e.g., FGFR3, PIK3CA). 3′ RACE is a useful method for identifying
